Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis
- 2 January 2019
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 18 (2) , 203-209
Abstract
Biallelic pathogenic variants (PVs) in MUTYH cause MUTYH-Associated Polyposis (MAP), which displays phenotypic overlap with other hereditary colorectal cancer (CRC) syndromes including Familial Adenomatous Polyposis (FAP) and Lynch syndrome. We report the phenotypic spectrum of MAP in the context of multi-gene hereditary cancer panel testing. Genetic testing results and clinical histories were reviewed for individuals with biallelic MUTYH PVs detected by panel testing at a single commercial molecular diagnostic laboratory. Biallelic MUTYH PVs were identified in 82 individuals (representing 0.2% of tested individuals) with most (75/82; 91.5%) reporting a personal history of CRC and/or polyps. Ten percent (6/61) of individuals reporting polyp number reported fewer than 10 polyps and therefore did not meet current MAP testing criteria. Extracolonic cancers (21/82; 25.6%), multiple primaries (19/82; 23.2%), Lynch-like (17/82; 20.7%) and FAP-like phenotypes (16/82; 19.5%) were observed, including individuals with mismatch repair-deficient tumors (3/82; 3.7%), sebaceous neoplasms (2/82; 2.4%), or congenital hypertrophy of the retinal pigment epithelium (CHRPE) (2/82; 2.4%). We report what is to our knowledge the first cohort of individuals with MAP identified by panel testing. The phenotypic spectrum of MAP observed in this cohort aligns with the published literature. In addition to standard indications for MUTYH testing, our data provide evidence to support consideration of MAP in the differential diagnosis for some individuals with fewer than 10 polyps, depending on other personal and/or family history, as well as for individuals suspected to have Lynch syndrome or FAP.Keywords
This publication has 31 references indexed in Scilit:
- MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancerGenetics in Medicine, 2018
- Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testingGenetics in Medicine, 2016
- Prevalence of germline MUTYH mutations among Lynch-like syndrome patientsEuropean Journal of Cancer, 2014
- Analysis of current testing practices for biallelicMUTYHmutations inMUTYH-associated polyposisClinical Genetics, 2014
- MUTYH‐associated polyposis – variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutationsClinical Genetics, 2010
- Expanded Extracolonic Tumor Spectrum in MUTYH-Associated PolyposisGastroenterology, 2009
- The Value of MUTYH Testing in Patients with Early Onset Microsatellite Stable Colorectal Cancer Referred for Hereditary Nonpolyposis Colon Cancer Syndrome TestingGenetic Testing, 2007
- Risk of Colorectal Cancer in Monoallelic and Biallelic Carriers of MYH Mutations: A Population-Based Case-Family StudyCancer Epidemiology, Biomarkers & Prevention, 2006
- Germline Susceptibility to Colorectal Cancer Due to Base-Excision Repair Gene DefectsThe American Journal of Human Genetics, 2005
- Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposisHuman Genetics, 1994